4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-044464
Options or other derivatives
- Chief Executive Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Katz Burton · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2008-02-04 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +300,000 | 300,000 | D |
Loading xslF345X03/v102280_ex.xml…